Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics Prime
$25.00
Provider: Sadif Analytics Prime
$10.00
Provider: Directors Deals Ltd.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Rhoen Klinikum AG Confirms FY 2013 Revenue, EBITDA and Net Profit Guidance


Thursday, 25 Apr 2013 01:00am EDT 

Rhoen Klinikum AG announced that it has confirmed its forecast for the fiscal year 2013 as a whole. In the fiscal year 2013, Rhoen Klinikum AG expects to achieve revenue in the range of 2.5% more or less than EUR 3.03 billion. This revenue target is accompanied by a fiscal year 2013 EBITDA forecast of EUR 325 million and a consolidated fiscal year 2013 net profit forecast of EUR 110 million, each with a fluctuation range of 5%. According to I/B/E/S Estimates, analysts on average are expecting the Company to report fiscal year 2013 revenue of EUR 3,028.08 million, EBITDA of EUR 330.37 million, and a net profit of EUR 113.94 million. 

Company Quote

23.33
0.1 +0.43%
23 Dec 2014